SELLAS Life Sciences Group (SLS) Return on Equity: 2013-2023
Historic Return on Equity for SELLAS Life Sciences Group (SLS) over the last 4 years, with Dec 2023 value amounting to 6.42%.
- SELLAS Life Sciences Group's Return on Equity rose 1123.00% to 6.42% in Q4 2023 from the same period last year, while for Dec 2023 it was 6.42%, marking a year-over-year increase of 1123.00%. This contributed to the annual value of 24.24% for FY2023, which is 2751.00% up from last year.
- Per SELLAS Life Sciences Group's latest filing, its Return on Equity stood at 6.42% for Q4 2023, which was up 108.33% from -77.04% recorded in Q3 2023.
- Over the past 5 years, SELLAS Life Sciences Group's Return on Equity peaked at 6.42% during Q4 2023, and registered a low of -77.04% during Q3 2023.
- Moreover, its 3-year median value for Return on Equity was -3.03% (2022), whereas its average is -8.01%.
- In the last 5 years, SELLAS Life Sciences Group's Return on Equity skyrocketed by 1,466bps in 2021 and then crashed by 7,426bps in 2023.
- Quarterly analysis of 4 years shows SELLAS Life Sciences Group's Return on Equity stood at -0.95% in 2020, then decreased by 13bps to -1.08% in 2021, then tumbled by 373bps to -4.81% in 2022, then skyrocketed by 1,123bps to 6.42% in 2023.
- Its Return on Equity was 6.42% in Q4 2023, compared to -77.04% in Q3 2023 and -4.10% in Q2 2023.